Health

  • March 27, 2026

    NC Biz Court Bulletin: Judge Exits, Duke Ducks Climate Suit

    The North Carolina Business Court saw an unexpected shakeup with one judge's retirement, rendered a pivotal decision in a first-of-its-kind climate change case against Duke Energy and oversaw a trial between the feuding owners of a commercial bed skirt company.

  • March 27, 2026

    5th Circ. Won't Revive Ex-Health IT Co. Worker's Bias Suit

    The Fifth Circuit upheld a healthcare information technology provider's win over a Black former manager's lawsuit claiming she was fired for complaining that a white male colleague was treated better, saying she couldn't overcome the company's rationale for letting her go.

  • March 27, 2026

    Hospital System Beats Most Of REIT's $50M Floodwall Suit

    A New York federal judge on March 27 mostly tossed a real estate investment trust's $50 million suit against the New York City Health and Hospitals Corp. and the NYC Economic Development Corp. over the design of a proposed floodwall for a downtown Manhattan life sciences campus project.

  • March 27, 2026

    Skincare Co. Says ITC Ruling Backs Ending PTAB Challenge

    Skin products company Hydrafacial has argued U.S. Patent and Trademark Office Director John Squires should turn down a rehearing request from rival Sinclair Pharma over Squires' order de-instituting a challenge to Hydrafacial's patent, saying a U.S. International Trade Commission decision upholding the same patent supports the director's move.

  • March 27, 2026

    Sens. Push Bill To Equip VA For Psychedelic Therapies

    A bipartisan group of U.S. senators has introduced legislation to broaden veterans' access to emerging therapies, including psychedelic-assisted treatments, that may be effective in addressing post-traumatic stress disorder and other mental health issues.

  • March 27, 2026

    Biopharma's Brass Hid Anxiety Drug Trial Risks, Investor Says

    Vistagen Therapeutics' current and former top brass have been hit with a derivative shareholder suit in California federal court alleging they overstated its clinical trial for a novel, anti-anxiety drug while hiding unpredictable placebo responses and other known risks, before the phase ultimately failed, causing a stock price collapse. 

  • March 27, 2026

    States Suspect ICE Obtained Medicaid Data Despite Order

    A coalition of states told a federal judge that the Trump administration appears to have ignored an order limiting the types of Medicaid data that can be shared with immigration officials, potentially handing over reams of "off limits" data on citizens and green card holders.

  • March 27, 2026

    Biogen Beats Investor Suit Over Dozens Of Drug Claims

    Biogen Inc. and four of its executives escaped a stock drop suit Friday after a Massachusetts federal judge ruled that none of the nearly five dozen statements challenged by investors suggested that the company intentionally misled people buying its stock.

  • March 27, 2026

    Mississippi Gov. Vetoes Medical Marijuana Expansion Bill

    Mississippi Gov. Tate Reeves has vetoed a bill to expand the state's medical cannabis program to include severely ill patients, while approving another bill to fund a clinical trial into the psychedelic ibogaine.

  • March 27, 2026

    Pa. Health Network's $1.15M 401(k) Suit Deal Gets Final OK

    A Pennsylvania federal judge gave the green light to a $1.15 million deal resolving a proposed class action alleging a healthcare system misused workers' forfeited employee retirement plan funds and failed to rein in administrative fees.

  • March 27, 2026

    Insurer Rips Sanctions Bid In Opioid Coverage Dispute

    An insurer asked an Illinois federal court to reject a drug wholesaler's bid for sanctions in a dispute over coverage for underlying opioid litigation, saying the accusations that it intentionally destroyed pertinent evidence are, "at best, based on half-truths and misstatements of fact."

  • March 27, 2026

    Colo. Nurses Snag Class Cert. In Holiday Pay Case

    A group of nurses can proceed as a class in a suit accusing a healthcare company of excluding holiday premiums from their pay when they worked overtime, a Colorado federal judge has ruled.

  • March 27, 2026

    Hospital Escapes Ex-Workers' 401(k) Forfeiture, Fund Suit

    A New York federal judge on Friday tossed a proposed class action against a healthcare company alleging mismanagement of an employee 401(k) plan, concluding that ex-workers who sued lacked standing to bring some claims while the remaining allegations weren't sufficiently backed up to state a claim for violating federal benefits law.

  • March 27, 2026

    Kirkland-Led Transcend Bought By Otsuka In $1.2B Deal

    Clinical-stage biotechnology company Transcend Therapeutics Inc., led by Kirkland & Ellis LLP, Pillsbury Winthrop Shaw Pittman LLP and Goodwin Procter LLP, on Friday announced that it has agreed to be bought by Otsuka Pharmaceutical Co. Ltd. in a deal worth up to $1.225 billion.

  • March 26, 2026

    Ex-Mich. City Workers Say Judge Erred In Trimming Vax Suit

    Former city employees of Ann Arbor, Michigan, asked a federal judge Thursday to reconsider her decision to remove religious discrimination and state civil rights claims from their suit alleging religious discrimination after they were denied COVID-19 vaccine exemptions.

  • March 26, 2026

    Imaging Practice Data Breach Class Actions Hit NC Biz Court

    A series of putative class actions resulting from a data breach at imaging practice Triad Radiology Associates PLLC hit North Carolina Business Court this week, with a couple of the cases naming hospitals that partnered with the practice.

  • March 26, 2026

    Co. Accused Of Sharing Mental Health Data With Google

    A California resident alleged in Colorado federal court that a Denver-based telehealth mental health provider is providing sensitive customer data to Google without their consent in violation of federal and state privacy laws, according to a proposed class action filed Thursday.

  • March 26, 2026

    Legislative Update: Cannabis And Psychedelics Bill Roundup

    Lawmakers at the state and federal level stewarded legislation to rein in kratom and its derivatives, Idaho lawmakers took a stand against a proposal to legalize medical marijuana via ballot initiative, and New York legislators introduced a plan to audit the state's cannabis regulator on an annual basis. Here are the major moves in cannabis and psychedelics legislation from the past week.

  • March 26, 2026

    Pregnancy 'Crisis' Center Loses Bid To End Deception Claims

    A Massachusetts federal judge on Thursday rejected a request by an anti-abortion nonprofit and a Missouri marketing firm to dismiss claims that they tried to trick women into visiting a pregnancy "crisis" center.

  • March 26, 2026

    Texas Court Won't Dismiss Patient's Cancer Misdiagnosis Suit

    A Texas appellate court has greenlighted a suit accusing a physician and two healthcare companies of misdiagnosing a patient with cancer, finding the plaintiff's expert report adequately outlined how the alleged negligence led to an unnecessary procedure.

  • March 26, 2026

    McDonald Hopkins Must Produce Fraud Warning Docs

    Midwestern law firm McDonald Hopkins LLC must produce email communications in connection with litigation accusing Blue Cross units of a smear campaign against a clinical lab owner, an Ohio federal judge ruled, finding the documents were not protected by work product or attorney-client privilege.

  • March 26, 2026

    U.S. Lawmakers Renew Tribal Child Abuse Prevention Bill

    A trio of U.S. lawmakers has reintroduced a bill that aims to strengthen available resources to Indigenous nations by filling gaps in the Child Abuse Prevention and Treatment Act to provide for more equitable access to grant funding opportunities.

  • March 26, 2026

    DOJ Says NY-Presbyterian Blocked Lower-Cost Health Plans

    New York-Presbyterian Hospital is forcing major health insurers to contract with it on an "all-or-nothing" basis, which is driving up healthcare costs in New York City and violates federal antitrust law, the U.S. Department of Justice said in a federal lawsuit filed Thursday. 

  • March 26, 2026

    9th Circ. Upholds Medtronic Win In Spinal Cord Device Suit

    A Washington man cannot sue medical device maker Medtronic USA Inc. on allegations it sold him a spinal cord implant that malfunctioned causing greater pain, the Ninth Circuit ruled, saying he lacked expert witnesses to support his negligence claims.

  • March 26, 2026

    Regeneron Can't Sink Disability Bias Claims Over Scheduling

    A former Regeneron Pharmaceuticals director can proceed with her lawsuit claiming she was fired for requesting a flexible schedule to care for her daughter, a New York federal judge ruled, saying she'd sufficiently backed up allegations that doing so had violated federal disability bias law.

Expert Analysis

  • Series

    Law School's Missed Lessons: What Cross-Selling Truly Takes

    Author Photo

    Early-career attorneys may struggle to introduce clients to practitioners in other specialties, but cross-selling becomes easier once they know why it’s vital to their first years of practice, which mistakes to avoid and how to anticipate clients' needs, say attorneys at Moses & Singer.

  • How State FCA Activity May Affect Civil Fraud Enforcement

    Author Photo

    A growing trend of state attorneys general enforcing their False Claims Act analogues independently of the U.S. Department of Justice carries potential repercussions for civil fraud enforcement and qui tam litigation considerations, say Li Yu at Bernstein Litowitz, Ellen London at London & Naor and Gwen Stamper at Vogel Slade.

  • Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms

    Author Photo

    Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Assessing Compliance Risks Around TrumpRx Participation

    Author Photo

    As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.

  • California's New Privacy Laws Demand Preparation From Cos.

    Author Photo

    An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Predicting Actual Impact From CDC's New Vaccine Guidance

    Author Photo

    Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.

  • AI Scientific Discovery Order Implications For Life Sciences

    Author Photo

    President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.

  • What Rescheduling Means For Cannabis Labels, Marketing

    Author Photo

    The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.

  • What's At Stake In Possible Circuit Split On Medicaid Rule

    Author Photo

    A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.

    Author Photo

    In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.

  • Unpacking Dormant Commerce Clause Cannabis Circuit Split

    Author Photo

    Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.

  • Remote Patient Monitoring Is At Regulatory Inflection Point

    Author Photo

    With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.